[
    {
        "title": "A randomized double-blind crossover comparison of risperidone and haloperidol in Korean Dementia patients with behavioral disturbances Suh GH, Son HG, Ju YS, Jcho KH, Yeon BK, Shin YM, Kee BS, Choi SK. Am J Geriatr Psych 2004;12(5):509-516",
        "paper_uid": "2271541c",
        "reference": "A randomized double-blind crossover comparison of risperidone and haloperidol in Korean Dementia patients with behavioral disturbances Suh GH, Son HG, Ju YS, Jcho KH, Yeon BK, Shin YM, Kee BS, Choi SK. Am J Geriatr Psych 2004;12(5):509-516",
        "save_folder_path": null,
        "study_design": "Randomized Controlled Trial",
        "characteristics": {
            "Number of patients randomized": "120 AD: 79; VaD: 34; Mixed AD-VaD: 7",
            "Age Haloperidol": "81.5 (7.7) Haloperidol-to-risperidone",
            "Age intervention": "80.4 (5.6) Risperidone-to-haloperidol",
            "MMSE Haloperidol": "9.4 (5.2) MMSE korean version",
            "MMSE intervention": "9.7 (7.5)"
        }
    },
    {
        "title": "Olanzapine versus Haloperidol in the Treatment of Agitation in Elderly Patients with Dementia: Results of a Randomized Controlled Double-Blind Trial. Verhey FR, Verkaaik M, Lousberg R. Dementia Geriatric Cogn Dis 2005;21(1):1-8",
        "paper_uid": "793447a7",
        "reference": "Olanzapine versus Haloperidol in the Treatment of Agitation in Elderly Patients with Dementia: Results of a Randomized Controlled Double-Blind Trial. Verhey FR, Verkaaik M, Lousberg R. Dementia Geriatric Cogn Dis 2005;21(1):1-8",
        "save_folder_path": null,
        "study_design": "Randomized Controlled Trial",
        "characteristics": {
            "Number of patients randomized": "58",
            "Age haloperidol": "82.4",
            "Mean age intervention": "83.3 (8.1)",
            "Mean MMSE Haloperidol": "10.9 (7.2)",
            "Mean MMSE intervention": "10 (7.7)"
        }
    },
    {
        "title": "A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Chan W, Lam LC, Choy CN, Leung VP, Li S, Chiu H. International J Geriatr Psych 2001;16(12):1156-1162 ",
        "paper_uid": "8c317dba",
        "reference": "A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Chan W, Lam LC, Choy CN, Leung VP, Li S, Chiu H. International J Geriatr Psych 2001;16(12):1156-1162 ",
        "save_folder_path": null,
        "study_design": "Randomized Controlled Trial",
        "characteristics": {
            "Number of patients randomized": "120",
            "Mean age Haloperidol": "80.8 (6.8)",
            "Mean age intervention": "80.2 (9.7)",
            "Mean MMSE Haloperidol": "8.2 (5)",
            "Mean MMSE intervention": "7.9 (6)"
        }
    },
    {
        "title": "A randomized trial of risperidone placebo and haloperidol for behavioral symptoms of dementia. De Deyn PP Rabheru K Rasmussen A Bocksberger JP Dautzenberg PLJ Eriksson S et al. Neurology 1999;53(5):946\u2013946",
        "paper_uid": "64979d7f",
        "reference": "A randomized trial of risperidone placebo and haloperidol for behavioral symptoms of dementia. De Deyn PP Rabheru K Rasmussen A Bocksberger JP Dautzenberg PLJ Eriksson S et al. Neurology 1999;53(5):946\u2013946",
        "save_folder_path": null,
        "study_design": "Randomized Controlled Trial",
        "characteristics": {
            "Number of patients randomized": "230 Randomized to either haloperidol or risperidone",
            "Mean age Haloperidol": "82 (56/97) Median (min/max)",
            "Mean age intervention": "81 (68/97) Median (min/max)",
            "Mean MMSE Haloperidol": "7.9 (6.1- 9.2) ",
            "Mean MMSE intervention": "8.6 (7.5 - 9.8)"
        }
    }
]